West Lafayette, IN, United States of America

John M Cassady

This inventor holds 1 USPTO granted patent. Top assignees: Eli Lilly and Company, Purdue Research Foundation. Active years: 1983.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John M Cassady. Retrieved from https://idiyas.com/inventor/john-m-cassady-631hnlvb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1983

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of John M. Cassady

Introduction

John M. Cassady is a notable inventor based in West Lafayette, IN (US). He has made significant contributions to the field of pharmacology, particularly in the area of dopamine autoreceptors. His work has implications for understanding and treating various neurological conditions.

Latest Patents

John M. Cassady holds a patent for the use of 4-(2-di-n-propylaminoethyl)indole or a salt thereof. This compound is utilized to stimulate presynaptic dopamine autoreceptors in mammals. His innovative approach has the potential to influence therapeutic strategies in neuroscience.

Career Highlights

Throughout his career, Cassady has worked with prominent organizations such as Eli Lilly and Company and Purdue Research Foundation. His experience in these institutions has allowed him to develop and refine his research in pharmacological applications.

Collaborations

One of his notable collaborators is James A. Clemens. Their partnership has contributed to advancements in their respective fields.

Conclusion

John M. Cassady's work exemplifies the impact of innovative thinking in the realm of pharmacology. His contributions continue to influence research and development in neuroscience.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…